Lower Limb Veins Should be Systematically Explored in Patients with Isolated Heparin-induced Thrombocytopenia

Thromb Haemost 1999; 82(03): 1199-1200
DOI: 10.1055/s-0037-1614355

Letters to the Editor

Schattauer GmbH

B. Tardy

¹Groupe de Recherche sur la Thrombose, Centre Hospitalier et Universitaire de Saint-Etienne, France

,

B. Tardy-Poncet

¹Groupe de Recherche sur la Thrombose, Centre Hospitalier et Universitaire de Saint-Etienne, France

,

P. Fournel

¹Groupe de Recherche sur la Thrombose, Centre Hospitalier et Universitaire de Saint-Etienne, France

,

C. Venet

¹Groupe de Recherche sur la Thrombose, Centre Hospitalier et Universitaire de Saint-Etienne, France

,

R. Jospe

¹Groupe de Recherche sur la Thrombose, Centre Hospitalier et Universitaire de Saint-Etienne, France

,

A. Dacosta

¹Groupe de Recherche sur la Thrombose, Centre Hospitalier et Universitaire de Saint-Etienne, France

References
1 Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995; 332: 1374-6.
2 Hirsh J, Warkentin TE, Raschke R, Granger CB, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanism of action, pharmacokinetics, dosing, considerations, monitoring, efficacy and safety. Chest 1998; 114: 489S-510S.
3 Boon DMS, Michiels JJ, Stibbe J, van Vliet HHDM, Kappers-Klunne MC. Heparin-induced thrombocytopenia and antithrombotic therapy. Lancet 1994; 344: 1296.
4 Warkentin TE, Kelton JG. A 14-year study of Heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-7.